Fate Therapeutics (FATE) Reports Q4 Loss, Tops Revenue Estimates
Fate Therapeutics(FATE) Zacks Investment Research·2024-02-27 07:11Fate Therapeutics财务表现 - Fate Therapeutics在上个季度每股亏损为0.45美元，超过了Zacks Consensus Estimate的0.57美元的亏损预期[1] - Fate Therapeutics在过去四个季度中，四次超过了市场预期的每股收益[2] - Fate Therapeutics在2023年12月份的季度营收为168万美元，超过了Zacks Consensus Estimate的971.8%[3]